The first death in an outbreak of a new type of coronavirus was announced Saturday by officials in the central Chinese city of Wuhan.
An investigational vaccine to protect against respiratory syncytial virus infection has received Fast Track designation from the FDA.
A new type of coronavirus may be responsible for dozens of viral pneumonia illnesses in China.
The Infectious Diseases Group of the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (EORTC/MSGERC) have updated consensus definitions of invasive fungal diseases.
The incidence and prevalence of nontuberculous mycobacterial lung disease is increasing in the United States.
Reporting of all verified TB cases, countable and noncountable, to the National Tuberculosis Surveillance System is necessary for capturing the true burden of TB and providing high-quality data for TB surveillance.
Sputum isolates of Mycobacterium abscessus may not reflect a patient’s full bacterial diversity.
Shower aerosols may be a significant source of non-tuberculous mycobacteria exposure in homes.
Use of at least five drugs recommended for intensive-phase treatment, four drugs for continuation phase
In 60-year follow-up, significantly lower lung cancer rates seen for those with childhood BCG vaccination
Patients with viral respiratory infections exhibited poorer outcomes following transplantation compared with patients without infection.
Patients with established chronic lung allograft dysfunction may have a higher risk for respiratory syncytial virus infections, but lung function decline does not appear to be significantly affected.
Active acute respiratory illness surveillance can be implemented among patients and staff in an adult long-term care facility.
An outbreak of Legionnaires’ disease that has sickened 116 and killed one at the state fair may have started at a hot tub display.
Treatment for latent tuberculosis infection among patients between age 65 and 78 years has been shown to be relatively well tolerated, with completion rates decreasing according to age.
Revised NHANES-based estimate for prevalence of latent TB infection excludes those who report prior tx
Janssen announced that the Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for their investigational prophylactic vaccine for the prevention of respiratory syncytial virus (RSV)-mediated lower respiratory tract disease in adults aged 60 years and older. RSV is a highly prevalent and contagious respiratory infection. It is the most common cause of bronchitis…
Mycoplasma pneumoniae immunoglobulin M antibody-secreting cells were successfully used to differentiate between those with M pneumoniae infection and carriers in a pediatric population.
The FDA has approved Sirturo (bedaquiline; Janssen) for use in pediatric patients aged 12 to less than 18 years for MDR-TB.
All forms of rifampin-resistant tuberculosis may be positively associated with HIV and increased mortality.